Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 43,273 | 46,018 | 41,404 | 36,939 | 34,437 |
| Cost of Goods | 3,712 | 4,632 | 8,326 | 8,177 | 5,824 |
| Gross Profit | 39,561 | 41,386 | 33,078 | 28,762 | 28,613 |
| Operating Expenses | 186,127 | 117,085 | 133,041 | 84,215 | 66,727 |
| Operating Income | -145,854 | -75,067 | -99,637 | -55,276 | -37,290 |
| Interest Expense | 14 | 1,247 | 3,189 | 5,498 | 7,257 |
| Other Income | 15,088 | 5,602 | 572 | 2,357 | -847 |
| Pre-tax Income | -130,780 | -70,712 | -102,254 | -58,417 | -45,394 |
| Income Tax | 90 | 83 | N/A | N/A | N/A |
| Net Income Continuous | -130,870 | -70,795 | -102,254 | -58,417 | -45,394 |
| Net Income | $-130,870 | $-70,795 | $-102,254 | $-58,417 | $-45,394 |
| EPS Basic Total Ops | -2.32 | -1.82 | -2.74 | -2.03 | -3.54 |
| EPS Basic Continuous Ops | -2.32 | -1.82 | -2.74 | -2.03 | -3.54 |
| EPS Diluted Total Ops | -2.32 | -1.82 | -2.74 | -2.03 | -3.54 |
| EPS Diluted Continuous Ops | -2.32 | -1.82 | -2.74 | -2.03 | -3.54 |
| EPS Diluted Before Non-Recurring Items | -2.32 | -1.82 | -2.15 | -2.03 | -3.47 |
| EBITDA(a) | $-150,267 | $-75,459 | $-77,050 | $-51,877 | $-33,896 |